Discover circulating microRNA as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism

碩士 === 國立陽明大學 === 微生物及免疫學研究所 === 103 === Endothelial progenitor cells (EPCs) has been found to have the potential to promote vessel repair and their dysfunction has been reported in coronary artery disease (CAD) patients .Many studies show that there are lots of miRNAs up regulated in CAD EPCs and t...

Full description

Bibliographic Details
Main Authors: Hsiu-Yen Ma, 馬秀燕
Other Authors: Hsei-Wei Wang
Format: Others
Language:zh-TW
Published: 2015
Online Access:http://ndltd.ncl.edu.tw/handle/02659853019034828464
id ndltd-TW-103YM005380019
record_format oai_dc
spelling ndltd-TW-103YM0053800192016-12-04T04:07:59Z http://ndltd.ncl.edu.tw/handle/02659853019034828464 Discover circulating microRNA as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism 從冠狀動脈疾病病人血漿中找尋有做為潛力性生物標記的微小核醣核酸並探討其調控機制 Hsiu-Yen Ma 馬秀燕 碩士 國立陽明大學 微生物及免疫學研究所 103 Endothelial progenitor cells (EPCs) has been found to have the potential to promote vessel repair and their dysfunction has been reported in coronary artery disease (CAD) patients .Many studies show that there are lots of miRNAs up regulated in CAD EPCs and they will inhibit angiogenesis. In our studies, we find that treating healthy EPCs with CAD EPCs- derived cultured medium and cultured medium exosomes can inhibit EPCs ability of tube formation and migration. We guess miRNAs in EPCs will release to culture medium and go into EPCs to regulate cells functions and they also could release to plasma form EPCs. Coronary artery disease is increasing in recent years. Early detecting CAD can prevent myocardial infarction and sudden cardiac death and therefore we want to find out biomarkers to early detect CAD. Besides early detect CAD, biomarkers also can help to assess vascular status after drug therapy. Studies show miRNAs have many properties to become good biomarkers ; therefore, we search miRNAs form plasma. We find that miR-146a-5p、miR-146b-5p、NM-4791、miR-99b-5p、miR-127-3p、miR-210-3p、miR-26a-5p are up-regulated in CAD plasma and they may become CAD potential biomarkers. To investigate regulatory mechanism of these miRNAs, we find miR-210-3p、miR-146b-5p、miR-26a-5p、miR-127-3p could target mitochondria related genes .Therefore, we test mitochondria function in healthy and CAD EPCs and we find that there are no difference between healthy and CAD EPCs. CAD is ischemic heart disease; therefore, cells could be in hypoxia environment. Thus, we treat EPCs with hypoxia and test mitochondria function. Results show that CAD EPCs have higher basal respiration, maximal respiration and ATP Production after treat them with hypoxia. Studies show that peripheral blood mononuclear cells of diabetes mellitus patients have the same phenomenon and it is a direction for further investigation. Hsei-Wei Wang 王學偉 2015 學位論文 ; thesis 75 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立陽明大學 === 微生物及免疫學研究所 === 103 === Endothelial progenitor cells (EPCs) has been found to have the potential to promote vessel repair and their dysfunction has been reported in coronary artery disease (CAD) patients .Many studies show that there are lots of miRNAs up regulated in CAD EPCs and they will inhibit angiogenesis. In our studies, we find that treating healthy EPCs with CAD EPCs- derived cultured medium and cultured medium exosomes can inhibit EPCs ability of tube formation and migration. We guess miRNAs in EPCs will release to culture medium and go into EPCs to regulate cells functions and they also could release to plasma form EPCs. Coronary artery disease is increasing in recent years. Early detecting CAD can prevent myocardial infarction and sudden cardiac death and therefore we want to find out biomarkers to early detect CAD. Besides early detect CAD, biomarkers also can help to assess vascular status after drug therapy. Studies show miRNAs have many properties to become good biomarkers ; therefore, we search miRNAs form plasma. We find that miR-146a-5p、miR-146b-5p、NM-4791、miR-99b-5p、miR-127-3p、miR-210-3p、miR-26a-5p are up-regulated in CAD plasma and they may become CAD potential biomarkers. To investigate regulatory mechanism of these miRNAs, we find miR-210-3p、miR-146b-5p、miR-26a-5p、miR-127-3p could target mitochondria related genes .Therefore, we test mitochondria function in healthy and CAD EPCs and we find that there are no difference between healthy and CAD EPCs. CAD is ischemic heart disease; therefore, cells could be in hypoxia environment. Thus, we treat EPCs with hypoxia and test mitochondria function. Results show that CAD EPCs have higher basal respiration, maximal respiration and ATP Production after treat them with hypoxia. Studies show that peripheral blood mononuclear cells of diabetes mellitus patients have the same phenomenon and it is a direction for further investigation.
author2 Hsei-Wei Wang
author_facet Hsei-Wei Wang
Hsiu-Yen Ma
馬秀燕
author Hsiu-Yen Ma
馬秀燕
spellingShingle Hsiu-Yen Ma
馬秀燕
Discover circulating microRNA as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism
author_sort Hsiu-Yen Ma
title Discover circulating microRNA as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism
title_short Discover circulating microRNA as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism
title_full Discover circulating microRNA as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism
title_fullStr Discover circulating microRNA as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism
title_full_unstemmed Discover circulating microRNA as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism
title_sort discover circulating microrna as potential biomarkers from the plasma of coronary artery disease patients and investigate their regulatory mechanism
publishDate 2015
url http://ndltd.ncl.edu.tw/handle/02659853019034828464
work_keys_str_mv AT hsiuyenma discovercirculatingmicrornaaspotentialbiomarkersfromtheplasmaofcoronaryarterydiseasepatientsandinvestigatetheirregulatorymechanism
AT mǎxiùyàn discovercirculatingmicrornaaspotentialbiomarkersfromtheplasmaofcoronaryarterydiseasepatientsandinvestigatetheirregulatorymechanism
AT hsiuyenma cóngguānzhuàngdòngmàijíbìngbìngrénxuèjiāngzhōngzhǎoxúnyǒuzuòwèiqiánlìxìngshēngwùbiāojìdewēixiǎohétánghésuānbìngtàntǎoqídiàokòngjīzhì
AT mǎxiùyàn cóngguānzhuàngdòngmàijíbìngbìngrénxuèjiāngzhōngzhǎoxúnyǒuzuòwèiqiánlìxìngshēngwùbiāojìdewēixiǎohétánghésuānbìngtàntǎoqídiàokòngjīzhì
_version_ 1718399098261864448